Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Anika Therapeutics (ANIK) over the last 16 years, with Q3 2025 value amounting to $60.5 million.

  • Anika Therapeutics' Retained Earnings fell 3532.16% to $60.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.5 million, marking a year-over-year decrease of 3532.16%. This contributed to the annual value of $71.7 million for FY2024, which is 4403.29% down from last year.
  • Per Anika Therapeutics' latest filing, its Retained Earnings stood at $60.5 million for Q3 2025, which was down 3532.16% from $62.8 million recorded in Q2 2025.
  • In the past 5 years, Anika Therapeutics' Retained Earnings ranged from a high of $231.4 million in Q3 2021 and a low of $60.5 million during Q3 2025
  • For the 5-year period, Anika Therapeutics' Retained Earnings averaged around $163.2 million, with its median value being $197.6 million (2023).
  • Its Retained Earnings has fluctuated over the past 5 years, first surged by 186.68% in 2021, then crashed by 5104.37% in 2024.
  • Anika Therapeutics' Retained Earnings (Quarter) stood at $225.6 million in 2021, then decreased by 6.59% to $210.7 million in 2022, then tumbled by 39.23% to $128.1 million in 2023, then plummeted by 44.03% to $71.7 million in 2024, then decreased by 15.59% to $60.5 million in 2025.
  • Its Retained Earnings stands at $60.5 million for Q3 2025, versus $62.8 million for Q2 2025 and $66.8 million for Q1 2025.